0,1,2,3,4,5,6,7
,,Country of origin,MERS-CoV RNA,MERS-CoV seroprevalence,,,
References,Study design,Year,presence,,Sex,Age,Imported/local
Wernery,Cross-,"UAE
2015",Nasal: 5% (45/871),ELISA: 93% (786/843),,<1Y: PCR: 35% (24/68),Farm
"et al.
[55]",sectional,,,,,ELISA 85% (92/108),
,,,,,,2â€“4Y: PCR: 3% (10/344),
,,,,,,ELISA 97% (328/340),
,,,,,,>4Y: PCR: 0% (0/250) ELISA,
,,,,,,96% (298/310),
Yusof et al.,Cross-,"UAE
2014",Nasal: 2% (126/7803),,,,KSA
